Page 2308 - Hematology_ Basic Principles and Practice ( PDFDrive )
P. 2308
2050 Part XII Hemostasis and Thrombosis
10. Casini A, Blondon M, Lebreton A: Natural history of patients with deficiency in the setting of systemic light-chain (AL)amyloidosis. Am J
congenital dysfibrinogenemia. Blood 125(3):553–561, 2015. Hematol 89(12):1153–1154, 2014.
11. Lancellotti S, Basso M, de Crisofaro R: Congenital Prothrombin Defi- 22. Duga S, Salomon O: Congenital factor XI deficiency: an update. Semin
ciency: an update. Semin Thromb Hemost 39(6):596–606, 2013. Thromb Hemost 39(6):621–631, 2013.
12. Peyvandi F, DiMichele D, Bolton-Maggs PHB, et al: Classification 23. Santoro C, Di Mauro R, Baldacci E, et al: Bleeding phenotype and
of rare bleeding disorders (RBDs) based on the association between correlation with factor XI (FXI) activity in congenital FXI deficiency:
coagulant factor activity and clinical bleeding severity. J Thromb Haemost results of a retrospective study from a single centre. Haemophilia
10(9):1938–1943, 2012. 21(4):496–501, 2015.
13. Thalji N, Camire RM: Parahemophilia: new insights into factor V 24. Bauduer F, de Raucourt E, Boyer-Neumann C, et al: Factor XI replace-
deficiency. Semin Thromb Hemost 39(6):607–612, 2013. ment for inherited factor XI deficiency in routine clinical practice:
14. Lippi G, Favaloro EJ, Montagnana M, et al: Inherited and acquired results of the HEMOLEVEN prospective 3-year postmarketing study.
factor V deficiency. Blood Coagul Fibrinolysis 22(3):160–166, 2011. Haemophilia 21(4):481–489, 2015.
15. DiMinno MN, Dolce A, Mariani G, et al: Bleeding symptoms at disease 25. De Jager T, Pericleous L, Kokot-Kierepa M, et al: The burden and man-
presentation and prediction of ensuing bleeding in inherited factor VII agement of factor XIII deficiency. Haemophilia 20(6):733–740, 2014.
deficiency. Thromb Haemost 109(6):1051–1059, 2013. 26. Schroeder V, Kohler HP: New developments in the area of factor XIII.
16. Mariani G, Napolitano M, Dolce A, et al: Replacement therapy for J Thromb Haemost 11(2):234–244, 2013.
bleeding episodes in factor VII deficiency. A prospective evaluation. 27. Hsu P, Zantek ND, Meijer P, et al: Factor XIII Assays and associated
Thromb Haemost 109(2):238–247, 2013. problems for laboratory diagnosis of factor XIII deficiency: an analysis
17. Siboni SM, Biguzzi E, Mistretta C, et al: Long-term prophylaxis in severe of International Proficiency testing results. Semin Thromb Hemost
factor VII deficiency. Haemophilia 21(6):812–819, 2015. 40(2):232–238, 2014.
18. Menegatti M, Peyvandi F: Factor X deficiency. Semin Thromb Hemost 28. Inbal A, Oldenburg J, Carcao M: Recombinant factor XIII: a safe
35(4):407–415, 2009. and novel treatment for congenital factor XIII deficiency. Blood
19. Lee G, Duan-Porter W, Metjian A: Acquired, non-amyloid related factor 119(22):5111–5117, 2012.
X deficiency: Review of the literature. Haemophilia 18(5):655–663, 29. Zheng C, Zhang B: Combined deficiency of coagulation factors V and
2012. VIII: an update. Semin Thromb Hemost 39(6):613–620, 2013.
20. Thompson CA, Kyle R, Gertz M, et al: Systemic AL amyloidosis with 30. Schulte R, Jordan LC, Morad A, et al: Rise in late onset vitamin K
acquired factor X deficiency: A study of perioperative bleeding risk and deficiency bleeding in young infants because of omission or refusal of
treatment outcomes in 60 patients. Am J Hematol 85(3):171–173, 2010. prophylaxis at birth. Pediatr Neurol 50(6):564–568, 2014.
21. Litvak A, Kumar A, Wong RJ, et al: Successful perioperative use of
prothrombin complex concentrate in the treatment of acquired factor X

